Alison Beauchamp
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (14)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Introduction There is growing evidence to support the use of co‐design in developing interventions across many disciplines. This scoping review aims to examine how co‐design methodology has been used in the development of cardiovascular disease (CVD) secondary prevention interventions within health and community settings. Methods We searched four academic databases for studies that used the co‐design approach to develop their intervention. Studies were included if consumers (adults with CVD) and key stakeholders (e.g. clinicians, service providers) were involved in the co‐design process. The review focused on methodology rather than traditional study outcomes; therefore, co‐design processes and activities were extracted and evaluated against a selected co‐design framework. Results Twenty‐two studies were included in this review. Studies were implemented across various settings with consumers and stakeholder groups most frequently consisting of patients and healthcare professionals, respectively. Most studies specifically stated that they used a ‘co‐design’ approach ( n = 10); others used terms such as participatory action research ( n = 3), user‐centred design ( n = 3) and community‐based participatory research ( n = 2). Although there was variability in terminology, co‐design processes, and participants, all studies adhered to the key principles of consumer engagement. Predominant co‐design activities included semistructured interviews, focus groups, co‐design/development workshops and advisory group meetings. Intervention effectiveness was assessed in eight studies showing mixed results. Conclusions This review provides an overview of how the co‐design approach has previously been used in the development of CVD secondary prevention interventions. These findings provide methodological considerations that can guide researchers and healthcare services when implementing co‐design to develop feasible and acceptable interventions that can improve outcomes for CVD populations. Patient or Public Contribution No patients, service users, caregivers, people with lived experience or members of the public were involved in this scoping review. This review article was written by academics who have undertaken a significant amount of co‐design work with consumers and stakeholders.
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (6)
Keith Sutton
MONASH UNIVERSITY
Robin M. Daly
-
Jaithri Ananthapavan
-
Brian Oldenburg
Head,
Baker Heart and Diabetes Institute
Anna Wong Shee
Associate Professor
-
Peter O'Meara
Adjunct Professor
Monash University - Peninsula Campus
Make your next move.
Prepare your application
Review drafts before you send them.